Evidence map›Paper›PMID 22986531›Full record

ArticleOncogene2013

Regulation of the tumor suppressor homeogene Cdx2 by HNF4α in intestinal cancer.

T Saandi, F Baraille, L Derbal-Wolfrom, A-L Cattin, F Benahmed, E Martin, P Cardot, B Duclos, A Ribeiro, J-N Freund and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Research on the circadian clock gene HNF4a in different malignant tumors.International journal of medical sciences · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. HNF4α and CDX2 Regulate IntestinalInternational journal of molecular sciences · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

T SaandiInserm, Unité 682, Strasbourg, France.
F Baraille
L Derbal-Wolfrom
A-L Cattin
F Benahmed
E Martin
P Cardot
B Duclos
A Ribeiro
J-N Freund
I Duluc
Inserm · FRCentre de Recherche des Cordeliers · FRSorbonne Université · FRUniversité Paris Cité · FR

Funding

Worldwide Cancer Research 08-0199
6 · The paper itself

Abstract

The gut-specific homeotic transcription factor Cdx2 is a crucial regulator of intestinal development and homeostasis, which is downregulated in colorectal cancers (CRC) and exhibits a tumor suppressor function in the colon. We have previously established that several endodermal transcription factors, including HNF4α and GATA6, are involved in Cdx2 regulation in the normal gut. Here we have studied the role of HNF4α in the mechanism of deregulation of Cdx2 in colon cancers. Crossing Apc(Δ14/+) mice prone to spontaneous intestinal tumor development with pCdx2-9LacZ transgenic mice containing the LacZ reporter under the control of the 9.3-kb Cdx2 promoter showed that this promoter segment contains sequences recapitulating the decrease of Cdx2 expression in intestinal cancers. Immunohistochemistry revealed that HNF4α, unlike GATA6, exhibited a similar decrease to Cdx2 in genetic (Apc(min/+) and Apc(Δ14/+)) and chemically induced (Azoxymethane (AOM) treatment) models of intestinal tumors in mice. HNF4α and Cdx2 also exhibited a comparable deregulated pattern in human CRC. Correlated patterns were observed between HNF4α and Cdx2 in several experimental models of human colon cancer cell lines: xenografts in nude mice, wound healing and glucose starvation. Furthermore, Cdx2 decreased by knocking down HNF4α in human colon cancer cells using siRNA and in the colon of mice conditionally knocked out for the Hnf4α gene in the adult intestine (Hnf4α(f/f);VilCre(ERT2) mice). Finally, the conditionally knocked out mice Hnf4α(f/f);VilCre(ERT2) treated with the carcinogen AOM developed colorectal tumors earlier than wild-type mice, as previously reported for mice with a reduced Cdx2 expression. In conclusion, this study provides evidence that the downregulation of HNF4α is an important determinant of the reduced expression of the Cdx2 tumor suppressor gene in intestinal cancers. Consistently, similar to Cdx2, HNF4α exerts a tumor suppressor function in the colon in that its loss of function facilitates tumor progression.

Indexed as

AnimalsCDX2 Transcription FactorColonic NeoplasmsGATA6 Transcription FactorGene Expression Regulation, NeoplasticGenes, Tumor SuppressorHepatocyte Nuclear Factor 4Homeodomain ProteinsMicePromoter Regions, GeneticTranscription FactorsCdx2 protein, mouseCDX2 Transcription FactorGata6 protein, mouseGATA6 Transcription FactorHepatocyte Nuclear Factor 4Hnf4a protein, mouseHomeodomain ProteinsTranscription Factors

Identifiers

PMID22986531
OpenAlexW2079860844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.